Clinical perspectives for the use of total body PET/CT

Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1712-1718. doi: 10.1007/s00259-021-05293-4.

Authors

Ronan Abgral^{1

2}, David Bourhis^{3

4}, Pierre-Yves Salaun^{3

4}

Affiliations

¹ Department of Nuclear Medicine, University Hospital of Brest, 2 avenue Foch, 29609, Brest cedex, France. ronan.abgral@chu-brest.fr.
² EA GETBO 3878, University of Western Brittany, Brest, France. ronan.abgral@chu-brest.fr.
³ Department of Nuclear Medicine, University Hospital of Brest, 2 avenue Foch, 29609, Brest cedex, France.
⁴ EA GETBO 3878, University of Western Brittany, Brest, France.

PMID: 33742236
DOI: 10.1007/s00259-021-05293-4

No abstract available

Publication types

Editorial

MeSH terms

Fluorodeoxyglucose F18*
Humans
Positron Emission Tomography Computed Tomography*
Positron-Emission Tomography
Whole Body Imaging

Substances

Fluorodeoxyglucose F18